Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Study: MRI fusion biopsy outperforms standard prostate biopsy

Researchers at the University of Cincinnati have found that MRI fusion biopsy--coupling MRI and ultrasound to visualize suspicious lesions in the prostate gland and targeting the biopsy to that particular area--outperformed standard prostate biopsy in patients with a prior negative prostate biopsy.

16 May 2018

Centrosome amplification may contribute to initiation of cancers, research suggests

Cells begin to accumulate centrosomes - organelles that play a vital role during cell division - before they transform into cancer cells, according to a new study of patients with Barrett's esophagus condition, which is associated with esophageal cancer.

8 May 2018

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck's anti-PD-1 therapy, KEYTRUDA®, along with chemotherapy.

8 May 2018

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

Today physicians are still severely hampered by the lack of precision of the needle tip location during a biopsy. Looking at lung cancers, 25% of the diagnoses suffer a false negative outcome through traditional biopsy methods. In the future, this can be avoided: for the first time, the European project InSPECT developed miniature spectrometers with integrated light sources enabling guided sensing.

8 May 2018

Novel 3D cancer model to accelerate development of new and better treatments

A scientist at the University of Virginia School of Medicine, working with local biotech company HemoShear Therapeutics, has created a three-dimensional model of a cancer tumor that he says has the potential to replicate the complex nature and behavior of a real tumor.

7 May 2018

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform sentinel lymph node biopsy (SLNB) recommendations.

7 May 2018

Researchers discover how a light touch can lead to unbearable itching

For some people, particularly those who are elderly, even a light touch of the skin or contact with clothing can lead to unbearable itching.

4 May 2018

Penn surgeons perform first ever robot-assisted complex spinal surgery for rare tumor removal

Noah Pernikoff is back to his life in New York City after becoming the first patient in the world to undergo a complex three-part, robotic-assisted surgery.

3 May 2018

Moving beyond traditional 'magic bullet' approach for discovering new drugs

It's time to move beyond the traditional 'magic bullet' approach for discovering new drugs and start leveraging the full complexity of Mother Nature, say Vanderbilt Professor of Chemistry Brian Bachmann and Assistant Professor of Cell and Developmental Biology Jonathan Irish.

3 May 2018

Nearly 50 people present with rare eye cancer - ocular melanoma

At least 50 people have been diagnosed with a rare type of eye cancer called ocular melanoma. They are all residents of two locations - Huntersville, North Carolina, and Auburn, Alabama. The cancer is rare and occurs in only six per 1 million population. The high rate of incidence of this cancer in these two locations has stumped researchers.

2 May 2018

Novel magnetic nanoparticles move from lab to first breast cancer clinical trials

Sandia National Laboratories materials chemist Dale Huber has been working on the challenge of making iron-based nanoparticles the exact same size for 15 years.

30 Apr 2018

Samsung RS85 ultrasound system receives FDA 510(k) clearance

NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that the Samsung RS85 ultrasound system has received FDA 510(k) clearance.

28 Apr 2018

Blood biopsies may offer more comprehensive genetic information than bone marrow tests, shows research

Bone marrow biopsies are the gold standard for diagnosing and monitoring the progression of multiple myeloma, but these procedures are far too invasive to perform at every patient visit.

27 Apr 2018

New noninvasive technique uses blood test to detect brain tumor biomarkers

Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.

26 Apr 2018

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an incision to get a bone marrow sample - or make a larger incision and remove a section of bone via surgery.

20 Apr 2018

Scientists develop tiny fluorescent probe that seeks out GLUT5 and detects cancer cells

Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology--a sugar-transporting biosensor--researchers at Michigan Technological University hope to reduce that timeframe down to minutes.

20 Apr 2018

Study: Inactivity of astronauts during spaceflights may have more pronounced effect on skeletal muscle than hypoxia

The inactivity of astronauts during spaceflights presents a significant risk to their muscles, says a new study in The Journal of Physiology. Scientists have simulated the impact of 21 day spaceflights on the body, and the impact of low gravity environments such as the Moon or Mars.

19 Apr 2018

Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens

Existing microscopy-based methods of detecting apoptosis, such as TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling), have limited quantitative capabilities due to insufficient signal-to-noise ratios.

19 Apr 2018

Physician assistants less likely to accurately diagnose early stage skin cancers

Physician assistants (PAs) are increasingly used in dermatology practices to cut costs and improve access to care, but are more likely than dermatologists to perform unnecessary skin biopsies to check for cancer, while being less likely to accurately diagnose early stage skin cancers, according to new research conducted by the University of Pittsburgh School of Medicine.

18 Apr 2018

Researchers evaluate accuracy of simple blood test to predict lung cancer

Every year, health care providers in the United States discover more than 1.6 million lung nodules in patients.

18 Apr 2018

Biopsy News and Research

Further Reading

Study: MRI fusion biopsy outperforms standard prostate biopsy

Centrosome amplification may contribute to initiation of cancers, research suggests

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

Novel 3D cancer model to accelerate development of new and better treatments

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Researchers discover how a light touch can lead to unbearable itching

Penn surgeons perform first ever robot-assisted complex spinal surgery for rare tumor removal

Moving beyond traditional 'magic bullet' approach for discovering new drugs

Nearly 50 people present with rare eye cancer - ocular melanoma

Novel magnetic nanoparticles move from lab to first breast cancer clinical trials

Samsung RS85 ultrasound system receives FDA 510(k) clearance

Blood biopsies may offer more comprehensive genetic information than bone marrow tests, shows research

New noninvasive technique uses blood test to detect brain tumor biomarkers

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

Scientists develop tiny fluorescent probe that seeks out GLUT5 and detects cancer cells

Study: Inactivity of astronauts during spaceflights may have more pronounced effect on skeletal muscle than hypoxia

Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens

Physician assistants less likely to accurately diagnose early stage skin cancers

Researchers evaluate accuracy of simple blood test to predict lung cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News